Our Parkinson's Place

WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Thursday, May 1, 2014

Parkinson’s Disease Vaccine Treatment Approach Awarded $8M

FoxFeed Blog


Posted by  Maggie McGuire, April 29, 2014
Parkinson’s Disease Vaccine Treatment Approach Awarded $8M
Yesterday Austrian biotech company AFFiRiS AG announced a €6 million euro (more than $8 million US dollars) grant from the European Union to continue developing vaccines against Parkinson’s disease (PD) and multiple system atrophy (MSA).
The Michael J. Fox Foundation granted AFFiRiS $1.5 million in November 2011 to conduct the Phase I clinical study of its PD vaccine drug candidate, PD01. Results from that study are expectedlater this year.
Both the PD and MSA vaccines target the protein alpha-synuclein, which clumps in the cells of people of both diseases. This protein aggregation leads to cell dysfunction and cell death. A therapy that could prevent or break up the clumps may be able to slow or stop the disease process.
Read more about this research or listen to a podcast.
“It’s important to bear in mind that PD01 is still in the early stages of clinical testing,” says Kuldip Dave, PhD, senior associate director of research programs at MJFF. “But we’re definitely paying close attention to the AFFiRiS approach. This is the first study to test a vaccine for Parkinson’s disease. If successful, it could be a game changer.”
The European Union funding is another success of the MJFF de-risking model, which supports early-stage research to capture data — such as on proof of concept or safety — that would make the project more attractive to larger, more risk-averse funders. The AFFiRiS project was previously funded €25 million (more than $34 million US dollars) by venture capitalists after the initial MJFF grant.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)